LAPTM4B and oral cavity carcinoma: In oral cavity carcinoma, expression of LAPTM4B-35 had no influence on OS (p = 0.4167 [Log Rank], p = 0.5947 [Gehan-Breslow]) or DFS (p = 0.7432 [Log Rank], p = 0.9303 [Gehan-Breslow]).